Press release
September 29, 2026
AhR Modulation by EQ504 Restores Immune Balance by Suppressing Pathogenic Th17/M1 Responses While Enhancing Regulatory Pathways<span>Jeanette Ampudia, et. al.</span><span> 7th Internation AHR Conference </span><span>2026</span>
Equillium, Inc. (EQ)
Skip to main content Skip to main content Home Company About Us Executive Team Board of Directors Scientific & Clinical Advisors Partners Pipeline Technology EQ504 EQ302 Publications Presentations Investors Investor Overview Stock Information Stock Chart Analyst Coverage Press Releases Events & Presentations Email Alerts & Contacts SEC Filings Corporate Governance Governance Documents Committee Composition Investor FAQs Careers Contact Us Search query Presentation Details Back AhR Modulation by EQ504 Restores Immune Balance by Suppressing Pathogenic Th17/M1 Responses While Enhancing Regulatory Pathways<span>Jeanette Ampudia, et. al.</span><span> 7th Internation AHR Conference </span><span>2026</span> 09/29/2026 Download this Press Release PDF Format (opens in new window) Jeanette Ampudia, et. al. Conference: 7th Internation AHR Conference Year: 2026 Stay Connected Stay Connected © Equillium Bio. - All rights reserved Privacy Notice Cookies Policy Powered By Q4 Inc. 5.188.0.4 (opens in new window)